These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12372706)
1. 10 years and counting: the hype and hope of cancer biotechnology. Morris K Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706 [No Abstract] [Full Text] [Related]
2. Gene-modified cells for the treatment of cancer. Whartenby KA; Abraham GN; Calabresi PA; Abboud CN; Calabresi P; Marrogi A; Freeman SM Pharmacol Ther; 1995 Apr; 66(1):175-90. PubMed ID: 7630929 [TBL] [Abstract][Full Text] [Related]
3. Molecular approaches to cancer therapy. Israel MA Adv Cancer Res; 1993; 61():57-85. PubMed ID: 8346720 [No Abstract] [Full Text] [Related]
4. Impact of Cancer Biotechnology on Diagnostic and Prognostic Indicators in Predictive Oncology and Therapy. Nice, France, October 26-28, 1996. Abstracts. Cancer Detect Prev; 1996; 20(5):391-555. PubMed ID: 8951217 [No Abstract] [Full Text] [Related]
5. Control of oncogene expression by antisense nucleic acids. Hélène C Eur J Cancer; 1994; 30A(11):1721-6. PubMed ID: 7833151 [No Abstract] [Full Text] [Related]
6. Antisense oligonucleotide technology in the development of cancer therapeutics. Tseng BY; Brown KD Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240 [No Abstract] [Full Text] [Related]
7. Clinical development of antisense oligonucleotides as anti-cancer therapeutics. Chen HX Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768 [No Abstract] [Full Text] [Related]
8. Bioinformatics in cancer therapeutics--hype or hope? Simon R Nat Clin Pract Oncol; 2005 May; 2(5):223. PubMed ID: 16264939 [No Abstract] [Full Text] [Related]
9. Oncology. Yoshida T; Terada M JAMA; 1997 Jun; 277(23):1880-1. PubMed ID: 9185814 [No Abstract] [Full Text] [Related]
10. European School of Oncology Task Force Papers: gene therapy--a future in cancer management? Antisense therapy for malignant disease. O'Brien SG; Kirkland MA; Goldman JM Eur J Cancer; 1994; 30A(8):1160-4. PubMed ID: 7654449 [No Abstract] [Full Text] [Related]
11. [Translational research in clinical oncology: challenges and opportunities]. Díaz-Rubio García E An R Acad Nac Med (Madr); 2008; 125(1):105-20; discussion 121-2. PubMed ID: 18777846 [TBL] [Abstract][Full Text] [Related]
12. Targeted and tailored therapy in hemato-oncology: vision for the 21st century. Shpilberg O; Ben-Bassat I; Raanani P Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100 [TBL] [Abstract][Full Text] [Related]
13. The current status of clinical gene therapy. Anderson WF Hum Gene Ther; 2002 Jul; 13(11):1261-2. PubMed ID: 12162809 [No Abstract] [Full Text] [Related]